Determination of phosphorylated residues from human respiratory syncytial virus P protein that are dynamically dephosphorylated by cellular phosphatases: a possible role for serine 54
The 241 aa human respiratory synctyial virus (HRSV) Long strain P protein is phosphorylated at serines 116, 117 and/or 119, and 232. Phosphates added to these residues have slow turnover and can be detected in the absence of protein phosphatase inhibition. Inhibition of phosphatases PP1 and PP2A increases the level of phosphorylation at serines 116, 117 and/or 119, suggesting a more rapid turnover for phosphates added to these residues compared to that of S232. High-turnover phosphorylation is detected in the P-protein NH2-terminal region, mainly at S54 and, to a lesser extent, at S39, in the Long strain. When the P protein bears the T46I substitution (in the remaining HRSV strains), phosphates are added to S30, S39, S45 and S54. Phosphatase PP1 removes phosphate at residues in the central part of the P-protein molecule, whereas those in the NH2-terminal region are removed by phosphatase PP2A. The significance of the phosphorylation of the NH2-terminal region residues for some P-protein functions was studied. The results indicated that this modification is not essential for P-protein oligomerization or for its role in viral RNA synthesis. Nonetheless, dephosphorylation at S54 could facilitate P–M protein interactions that probably occur during the egress of viral particles.
AlansariH.,
PotgieterL. N. D.1994; Molecular cloning and sequence analysis of the phosphoprotein, nucleocapsid protein, matrix protein and 22K (M2) protein of the ovine respiratory syncytial virus. J Gen Virol 75:3597–3601[CrossRef]
AlbertsA. S.,
MontminyM.,
ShenolikarS.,
FeramiscoJ. R.1994; Expression of a peptide inhibitor of protein phosphatase 1 increases phosphorylation and activity of CREB in NIH 3T3 fibroblasts. Mol Cell Biol 14:4398–4407
AsenjoA.,
VillanuevaN.2000; Regulated but not constitutive human respiratory syncytial virus (HRSV) P protein phosphorylation is essential for oligomerization. FEBS Lett 467:279–284[CrossRef]
BarikS.,
McLeanT.,
DupuyL. C.1995; Phosphorylation of Ser232 directly regulates the transcriptional activity of the P protein of human respiratory syncytial virus: phosphorylation of Ser237 may play an accessory role. Virology 213:405–412[CrossRef]
BialojanC.,
TakaiA.1988; Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem J 256:283–290
BitkoV.,
BarikS.1998; Persistant activation of RelA by respiratory syncytial virus involves protein kinase C, underphosphorylated I κ B β , and sequestration of protein phosphatase 2A by the viral phosphoprotein. J Virol 72:5610–5618
CastagnéN.,
BarbierA.,
BernardJ.,
RezaeiH.,
HuetJ.-C.,
HenryC.,
Da CostaB.,
EléouëtJ.-F.2004; Biochemical characterization of the respiratory syncytial virus P–P and P–N protein complexes and localization of the P protein oligomerization domain. J Gen Virol 85:1643–1653[CrossRef]
CollinsP. L.,
HillM. G.,
CamargoE.,
GrosfeldH.,
ChanockR. M.,
MurphyB. R.1995; Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc Natl Acad Sci U S A 92:11563–11567[CrossRef]
CollinsP. L.,
ChanockR. M.,
MurphyB. R.2001; Respiratory syncytial virus. In Fields Virology , 4th edn. pp 1443–1485 Edited by
KnipeD. M.,
HowleyP. M.
Philadelphia, PA: Lippincott Williams & Wilkins;
CuestaI.,
GengX.,
AsenjoA.,
VillanuevaN.2000; Structural phosphoprotein M2-1 of the human respiratory syncytial virus is an RNA binding protein. J Virol 74:9858–9867[CrossRef]
DasS. C.,
PattnaikA. S.2004; Phosphorylation of vesicular stomatitis virus phosphoprotein P is indispensable for virus growth. J Virol 78:6420–6430[CrossRef]
FalseyA. R.,
CunninghamC. K.,
BarkerW. H.,
KouidesR. W.,
YuenJ. B.,
MenegusM.,
WeinerL. B.,
BonvilleC. A.,
BettsR. F.1995; Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis 172:389–394[CrossRef]
FearnsR.,
PeeplesM. E.,
CollinsP. L.1997; Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome. Virology 236:188–201[CrossRef]
GaoY.,
LenardJ.1995; Multimerization and transcriptional activation of the phosphoprotein (P) of vesicular stomatitis virus by casein kinase-II. EMBO J 14:1240–1247
GubbayO.,
CurranJ.,
KolakofskyD.2001; Sendai virus genome synthesis and assembly are coupled: a possible mechanism to promote viral RNA polymerase processivity. J Gen Virol 82:2895–2903
HardyR. W.,
WertzG. W.1998; The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription. J Virol 72:520–526
HarringtonR. D.,
HootonT. M.,
HackmanR. C.,
StorchG. A.,
OsborneB.,
GleavesC. A.,
BensonA.,
MeyersJ. D.1992; An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 165:987–993[CrossRef]
HiguchiR.,
KrummelB.,
SaikiR. K.1988; A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res 16:7351–7367[CrossRef]
HorikamiS. M.,
CurranJ.,
KolakofskyD.,
MoyerS. A.1992; Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro. J Virol 66:4901–4908
LambR. A.,
KolakofskyD.2001; Paramyxoviridae : the viruses and their replication. In Fields Virology pp 1305–1340 Edited by
KnipeD. M.,
HowleyP. M.
Philadelphia, PA: Lippincott Williams & Wilkins;
LópezJ. A.,
VillanuevaN.,
MeleroJ. A.,
PortelaA.1988; Nucleotide sequence of the fusion and phosphoprotein genes of the human respiratory syncytial (RS) virus Long strain: evidence of subtype genetic heterogeneity. Virus Res 10:249–261[CrossRef]
LuB.,
MaC.-H.,
BrazasR.,
JinH.2002; The major phosphorylation sites of the respiratory syncytial virus phosphoprotein are dispensable for virus replication in vitro. J Virol 76:10776–10784[CrossRef]
MasonS. W.,
AbergE.,
LawetzC.,
DeLongR.,
WhiteheadP.,
LiuzziM.2003; Interaction between human respiratory syncytial virus (RSV) M2-1 and P proteins is required for reconstitution of M2-1-dependent RSV minigenome activity. J Virol 77:10670–10676[CrossRef]
MazumderB.,
BarikS.1994; Requirements of casein kinase II-mediated phosphorylation for the transcriptional activity of human respiratory syncytial viral phosphoprotein P: transdominant negative phenotype of phosphorylation-defective P mutants. Virology 205:104–111[CrossRef]
MazumderB.,
AdhikaryG.,
BarikS.1994; Bacterial expression of human respiratory syncytial viral phosphoprotein P and identification of Ser237 as the site of phosphorylation by cellular casein kinase II. Virology 205:93–103[CrossRef]
NavarroJ.,
López-OtínC.,
VillanuevaN.1991; Location of phosphorylated residues in human respiratory syncytial virus phosphoprotein. J Gen Virol 72:1455–1459[CrossRef]
PasteyM. K.,
GowerT. L.,
SpearmanP. W.,
CroweJ. E.Jr,
GrahamB. S.2000; A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3. Nat Med 6:35–40[CrossRef]
RodríguezL.,
CuestaI.,
AsenjoA.,
VillanuevaN.2004; Human respiratory syncytial virus matrix protein is an RNA-binding protein: binding properties, location and identity of the RNA contact residues. J Gen Virol 85:709–719[CrossRef]
Sánchez-SecoM. P.,
NavarroJ.,
MartínezR.,
VillanuevaN.1995; C-Terminal phosphorylation of human respiratory syncytial virus P protein occurs mainly at serine residue 232. J Gen Virol 76:425–430[CrossRef]
TranK. C.,
CollinsP. L.,
TengM. N.2004; Effects of altering the transcription termination signals of respiratory syncytial virus on viral gene expression and growth in vitro and in vivo. J Virol 78:692–699[CrossRef]
UlloaL.,
SerraR.,
AsenjoA.,
VillanuevaN.1998; Interactions between cellular actin and human respiratory syncytial virus (HRSV. Virus Res 53:13–25[CrossRef]
VillanuevaN.,
NavarroJ.,
CuberoE.1991; Antiviral effects of xanthate D609 on the human respiratory syncytial virus growth cycle. Virology 181:101–108[CrossRef]
VillanuevaN.,
NavarroJ.,
MéndezE.,
García-AlbertI.1994; Identification of a protein kinase involved in the phosphorylation of the C-terminal region of human respiratory syncytial virus P protein. J Gen Virol 75:555–565[CrossRef]
VillanuevaN.,
HardyR.,
AsenjoA.,
YuQ.,
WertzG.2000; The bulk of the phosphorylation of human respiratory syncytial virus phosphoprotein is not essential but modulates viral RNA transcription and replication. J Gen Virol 81:129–133
WhiteheadS. S.,
BukreyevA.,
TengM. N.,
FirestoneC.-Y.,
St ClaireM.,
ElkinsW. R.,
CollinsP. L.,
MurphyB. R.1999; Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees. J Virol 73:3438–3442
YuQ.,
HardyR. W.,
WertzG. W.1995; Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans -acting requirements for RNA replication. J Virol 69:2412–2419
Determination of phosphorylated residues from human respiratory syncytial virus P protein that are dynamically dephosphorylated by cellular phosphatases: a possible role for serine 54